Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 500

1.

Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.

Panburana P, Sirinavin S, Phuapradit W, Vibhagool A, Chantratita W.

Am J Obstet Gynecol. 2004 Mar;190(3):803-8.

PMID:
15042018
2.

Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.

Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A, Vanprapar N, Sirimai K, Chearskul S, Sutthent R, Opartkiattikul N.

Clin Infect Dis. 2002 Dec 1;35(11):1405-13. Epub 2002 Nov 12.

PMID:
12439805
3.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
4.

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL; South African Intrapartum Nevirapine Trial (SAINT) Investigators.

J Infect Dis. 2003 Mar 1;187(5):725-35. Epub 2003 Feb 24.

PMID:
12599045
5.

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

Suksomboon N, Poolsup N, Ket-Aim S.

J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.

PMID:
17489882
6.

Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.

Jourdain G, Mary JY, Coeur SL, Ngo-Giang-Huong N, Yuthavisuthi P, Limtrakul A, Traisathit P, McIntosh K, Lallemant M; Perinatal HIV Prevention Trial Group, Thailand.

J Infect Dis. 2007 Dec 1;196(11):1629-36. Epub 2007 Oct 25.

PMID:
18008246
7.

Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.

Makokha EP, Songok EM, Orago AA, Koech DK, Chemtai AK, Kobayashi N, Mpoke S, Tukei PM, Andayi FA, Lihana RW, Adungo NI, Vulule JM.

East Afr Med J. 2002 Nov;79(11):567-73.

PMID:
12630488
8.

An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection.

Grosch-Wörner I, Schäfer A, Obladen M, Maier RF, Seel K, Feiterna-Sperling C, Weigel R.

AIDS. 2000 Dec 22;14(18):2903-11.

PMID:
11153672
9.

Determinants of mother-to-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis.

Italian Register for Human Immunodeficiency Virus Infection in Children.

Arch Pediatr Adolesc Med. 2002 Sep;156(9):915-21.

PMID:
12197800
10.

Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study.

Kilewo C, Karlsson K, Massawe A, Lyamuya E, Swai A, Mhalu F, Biberfeld G; Mitra Study Team.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):315-23. doi: 10.1097/QAI.0b013e31816e395c.

PMID:
18344879
11.

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL.

N Engl J Med. 1996 Nov 28;335(22):1621-9.

12.

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring.

Moodley J, Moodley D, Pillay K, Coovadia H, Saba J, van Leeuwen R, Goodwin C, Harrigan PR, Moore KH, Stone C, Plumb R, Johnson MA.

J Infect Dis. 1998 Nov;178(5):1327-33.

PMID:
9780252
13.

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.

Kesho Bora Study Group, de Vincenzi I.

Lancet Infect Dis. 2011 Mar;11(3):171-80. doi: 10.1016/S1473-3099(10)70288-7. Epub 2011 Jan 13. Erratum in: Lancet Infect Dis. 2011 Mar;11(3):159. Read, Jennifer S [corrected to Read, Jennifer].

PMID:
21237718
14.

Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.

Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.

Clin Infect Dis. 2009 Jul 15;49(2):299-305. doi: 10.1086/599612.

PMID:
19522656
15.

Effect of immediate neonatal zidovudine on prevention of vertical transmission of human immunodeficiency virus type 1.

Sirinavin S S, Phaupradit W, Taneepanichskul S, Atamasirikul K, Hetrakul P, Thakkinstian A, Panburana P.

Int J Infect Dis. 2000;4(3):148-52.

PMID:
11179918
16.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

17.

Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.

Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK; NISDI Perinatal Study Group.

Obstet Gynecol. 2007 Jun;109(6):1358-67.

PMID:
17540808
18.

Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study.

Kilewo C, Karlsson K, Ngarina M, Massawe A, Lyamuya E, Swai A, Lipyoga R, Mhalu F, Biberfeld G; Mitra Plus Study Team.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):406-16. doi: 10.1097/QAI.0b013e3181b323ff.

PMID:
19730269
19.

Prevention of perinatal HIV transmission during pregnancy.

McGowan JP, Shah SS.

J Antimicrob Chemother. 2000 Nov;46(5):657-68. Review.

PMID:
11062184
20.

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.

N Engl J Med. 1994 Nov 3;331(18):1173-80.

Supplemental Content

Support Center